Further cellular functional assays and signaling pathway analyses validate that upregulation of IER3 significantly enhances the proliferative capabilities of CRC cells, potentially promoting inflammatory responses and cell survival signals through the NF-κB pathway [33,53,54,55]. The gene discussed is NFKB1; the disease is colorectal carcinoma.